US 11008304
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted A61PA61P1/16A61P13/12
Quick answer
US patent 11008304 (Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/16, A61P13/12, A61P25/28, A61P29/00